Clearpoint Neuro Inc (CLPT) financials
Clearpoint Neuro revenue and earnings by year
Clearpoint Neuro's revenue was $37.0 million in the fiscal year to December 31, 2025, up 17.8% from the year before. Net income was -$25.5 million, -69.1% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 23.0% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37 | 31 | 24 | 21 | 16 | 13 | 11 | 7 | 7 | 6 |
| Revenue growth | 17.8% | 31.0% | 16.6% | 26.1% | 27.0% | 14.4% | 52.5% | -0.4% | 28.4% | — |
| Gross profit | 23 | 19 | 14 | 14 | 11 | 9 | 7 | 5 | 4 | 3 |
| Gross margin | 61.4% | 60.9% | 56.8% | 65.8% | 68.2% | 71.1% | 64.9% | 66.9% | 60.7% | 54.0% |
| Operating income | -24 | -20 | -22 | -16 | -13 | -6 | -5 | -5 | -6 | -7 |
| Operating margin | -65.4% | -62.9% | -93.7% | -79.5% | -82.1% | -48.5% | -41.0% | -71.4% | -85.9% | -130.3% |
| Net income | -26 | -19 | -22 | -16 | -14 | -7 | -6 | -6 | -7 | -8 |
| Net margin | -69.1% | -60.3% | -92.2% | -80.0% | -88.4% | -52.9% | -49.4% | -83.8% | -97.1% | -140.4% |
| Diluted EPS | -$0.90 | -$0.70 | -$0.90 | -$0.68 | -$0.69 | -$0.43 | -$0.42 | -$0.56 | -$0.93 | -$3.05 |
| Free cash flow | -24 | -9 | -15 | -17 | -13 | -8 | -3 | -5 | -6 | -6 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CLPT in Markets.
How Clearpoint Neuro makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Neurosurgery Navigation & Therapy Disposable Products | $5.44M | 45.0% |
| Biologics & Drug Delivery Services & License Fees | $3.71M | 30.7% |
| Capital Equipment & Software Systems & Software Products | $1.27M | 10.5% |
| Biologics & Drug Delivery Disposable Products | $1.19M | 9.8% |
| Capital Equipment & Software Services | $474K | 3.9% |
See also: CLPT returns
No forecast, no recommendation. This page describes Clearpoint Neuro Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.